The epidemiology of heart failure in the general Australian community - study of heart failure in the Australian primary carE setting (SHAPE): methods

Table 3 Heart failure specific medications

Ivabradine
Ethacrynic acid
Eplerenone
Bisoprolol
Nebivolol
Carvedilol
Metoprolol succinate (HF doses only^a)
Sacubitril / Valsartan

Source: SHAPE Project Collaborators Expert Opinion, September 2018
In Australia, these medications have a restricted use benefit in the Pharmaceutical Benefits Scheme to ‘moderate to severe heart failure’ only. For example: https://www.pbs.gov.au/medicine/item/8733P for metoprolol succinate
^aDoses 23.75 mg, 47.5 mg, 95 mg, 190 mg (controlled release)

ISSN: 1471-2458